Assembly Concurrent Resolution ACR 99 declares June 29, 2025, as Scleroderma Awareness Day in California and affirms the Legislature’s support for medical research, advocacy, and the well‑being of people living with scleroderma. The text summarizes the disease, notes its prevalence and demographic patterns, and cites the Scleroderma Foundation of California’s education and outreach work.
The resolution is ceremonial and nonbinding: it does not appropriate funds, create programs, or change regulatory obligations. Its practical effect is limited to formal recognition that can be used by advocates and health communicators to coordinate awareness activities, outreach, and fundraising around the designated date.
At a Glance
What It Does
The resolution formally designates June 29, 2025, as Scleroderma Awareness Day in California, acknowledges the disease’s health and socioeconomic impacts, and expresses the Legislature’s support for research and advocacy. It also directs that copies of the resolution be transmitted by the Chief Clerk of the Assembly to the author for distribution.
Who It Affects
People living with scleroderma, caregivers, advocacy organizations (notably the Scleroderma Foundation of California), clinicians who treat autoimmune diseases, and public‑health communicators who plan outreach campaigns. It does not impose obligations on state agencies or private entities or create new funding streams.
Why It Matters
Formal recognition can increase visibility, give advocates a legislative hook for media and fundraising, and encourage local events and provider outreach around early diagnosis and care. But because the resolution includes no appropriations or mandates, its primary value lies in signaling and coordination rather than direct policy change.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
ACR 99 is a ceremonial, chaptered concurrent resolution that the Legislature used to place a formal, one‑time marker on the calendar: June 29, 2025, is declared Scleroderma Awareness Day in California. The body of the resolution compiles a series of 'whereas' statements that describe scleroderma’s clinical manifestations, the typical demographic profile of patients, the disease’s diagnostic challenges, and the psychosocial and economic burdens faced by patients and families.
Rather than creating a new program or directing state resources, the resolution highlights the role of the Scleroderma Foundation of California and affirms the Legislature’s support for ongoing research, education, and advocacy. It includes an administrative instruction that the Chief Clerk of the Assembly transmit copies of the resolution to the author for distribution, which is the typical mechanism for disseminating ceremonial resolutions to stakeholders.Legally, a concurrent resolution is nonbinding: it expresses the Legislature’s collective position but does not change state law, require agency action, or appropriate money.
The legislative digest for ACR 99 notes no fiscal committee referral, indicating no expected budgetary impact. Practically, the resolution gives patient groups and clinicians a formal date to anchor awareness campaigns, press outreach, and fundraising appeals, but any concrete follow‑on — grants, new clinical programs, insurance changes — would require separate legislation or administrative action.
The Five Things You Need to Know
The resolution designates June 29, 2025, as Scleroderma Awareness Day in California.
ACR 99 is a concurrent resolution—symbolic and nonbinding—so it creates no legal duties or funding obligations for state agencies.
The text explicitly cites the Scleroderma Foundation of California and affirms support for medical research, education, and advocacy efforts.
The Chief Clerk of the Assembly is instructed to transmit copies of the resolution to the author for distribution to stakeholders.
The bill was chaptered as Chapter 154 and contains no fiscal impact according to the legislative digest.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Summarizes the disease and builds the case for awareness
The preamble collects medical and demographic facts about scleroderma—distinguishing localized and systemic forms, noting organ involvement and diagnostic difficulty, and citing prevalence and gender/age patterns. Practically, this section performs two functions: it supplies factual justification for the declaration, and it signals to clinicians, researchers, and advocates the Legislature’s understanding of the disease’s complexity and burden.
Declares June 29, 2025, Scleroderma Awareness Day
This operative paragraph is the core deliverable: a formal designation of a specific calendar date. The language affirms the state’s support for people affected by scleroderma and for research and advocacy, but it does not institute any ongoing observance or require actions beyond public recognition.
Affirms goals: awareness, early diagnosis, mobilization of resources
Beyond naming the day, the resolution states the intended policy goals—enhanced public understanding, promotion of early diagnosis and treatment, and mobilization of community support. These are aspirational targets intended to guide stakeholders’ use of the observance, not enforceable requirements on state or private actors.
Transmission and distribution logistics
A short closing paragraph directs the Chief Clerk to transmit copies of the resolution to the author for appropriate distribution. This is a standard logistical clause that ensures the resolution reaches advocacy groups, the press, and other interested parties; it also documents the Legislature’s formal action for the public record.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- People living with scleroderma in California — gain heightened public visibility and a legislative acknowledgment that can support advocacy, community recognition, and provider outreach focused on early diagnosis and support services.
- Scleroderma Foundation of California — receives a legislative endorsement that advocates can cite in fundraising, public education, and awareness campaigns, strengthening partnerships with clinicians and media.
- Clinicians and specialty clinics (rheumatology, dermatology, pulmonology) — can leverage the designated day for patient education events, screening drives, and cross‑specialty coordination without needing legislative or regulatory prompts.
Who Bears the Cost
- State agencies and the General Fund — bear no mandated financial cost, but legislative and clerical staff incur minimal administrative time to process and distribute the resolution.
- Nonprofits and advocacy groups — may reallocate staff time and program budgets to mount awareness activities around the date; these are opportunity costs not covered by the resolution.
- Healthcare providers who choose to participate — may absorb costs for community events, outreach materials, or extended clinic hours if they use the day for additional services, with no state reimbursement.
Key Issues
The Core Tension
The central dilemma is symbolic recognition versus concrete action: the Legislature can raise visibility through a ceremonial declaration, but that signal achieves little without accompanying resources, accountability, or policy change—leaving advocates to convert symbolic momentum into tangible improvements in care and research funding.
ACR 99 is useful as a signaling device but limited in policy reach. Its symbolic value depends entirely on downstream activity by nonprofits, clinicians, and media; the resolution itself creates no mechanism to measure awareness gains, fund research, or change clinical practice.
That raises implementation questions: will stakeholders treat this as a one‑off communications opportunity tied to 2025, or will they use it to establish recurring programs? The resolution names the Scleroderma Foundation of California, effectively delegating much of the operational follow‑through to that nonprofit and similar groups, which may stretch limited organizational resources.
Another practical tension is calendar specificity. By naming a single date—June 29, 2025—the resolution avoids committing the Legislature to an annual observance.
Advocates seeking a recurring, institutionalized awareness day would need further legislative action. Finally, because the resolution states no funding or statutory change, any systemic deficiencies highlighted (for example, access to multidisciplinary care or insurance coverage gaps) remain unaddressed unless separate, substantive bills or administrative initiatives follow.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.